

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 1 | 2 | — | — | — | 2 |
| Hyperplasia | D006965 | EFO_0000536 | — | 1 | 2 | — | — | — | 2 |
| Lower urinary tract symptoms | D059411 | EFO_0008008 | — | — | 1 | — | — | — | 1 |
| Drug common name | LEMUTEPORFIN |
| INN | lemuteporfin |
| Description | Lemuteporfin is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | benzoporphyrin derivatives |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)OCCC)C(CCC(=O)OCCO)=C4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC |
| PDB | — |
| CAS-ID | 215808-49-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2107756 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | EZ109VJ012 (ChemIDplus, GSRS) |
